Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J STD AIDS. 2013 Jun;24(6):423-6. doi: 10.1177/0956462412473383. Epub 2013 Jul 10.

Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?

Author information

1
World Health Organization Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Örebro University Hospital, Örebro, Sweden. magnus.unemo@orebroll.se

Abstract

Gonorrhoea is a major public health concern globally. Of particular grave concern is that resistance to the third generation cephalosporins has been identified during recent years. This paper summarises and discusses the results of the '2012 IUSTI European Collaborative Clinical Group (ECCG) report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe'. Although high quality care was reported in many settings, in several other countries the testing, diagnostics, antimicrobial treatment and follow-up of gonorrhoea patients need to be optimized. This, together with increased access to and use of antimicrobial susceptibility testing, is crucial in controlling the emergent spread of cephalosporin-resistant and multidrug-resistant gonorrhoea.

KEYWORDS:

Europe; Gonorrhoea; Neisseria gonorrhoeae; cefixime; ceftriaxone; diagnosis; sexually transmitted infection; treatment

PMID:
23970742
DOI:
10.1177/0956462412473383
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center